Guest guest Posted January 9, 2001 Report Share Posted January 9, 2001 Colorectal cancer risk increased 3-fold in alpha-1-antitrypsin deficient carriers http://news2email.com/news.shtml?e14006221 Reuters Health Cancer Drug Developer Gets Partners http://news2email.com/news.shtml?e13996478 reg http://www.nytimes.com/auth/login?Tag=/ & Url= New York Times I beat cancer http://news2email.com/news.shtml?e13990649 BBC Cancer girl ready for school http://news2email.com/news.shtml?e13990633 BBC Anti-cancer pill launch plan lifts Phytopharm http://news2email.com/news.shtml?e13986145 The Times Health Professionals Should Ask Women About Family Breast Cancer History http://news2email.com/news.shtml?e13985964 Doctors Guide Mapping cervical cancer http://news2email.com/news.shtml?e13980718 BioMedNet Vaccine for Pancreatic Cancer http://news2email.com/news.shtml?e13980682 Medical Breakthroughs Painkillers Cut Colon Cancer Risk http://news2email.com/news.shtml?e13980697 Medical Breakthroughs Women Need Pressing About Any Family Breast Cancer History http://news2email.com/news.shtml?e13977838 Doctors Guide Analysts International Donates Development of Ecommerce Web Site to Childrens Cancer Research Fund http://news2email.com/news.shtml?e13975508 Java Industry Connection Strengthening of Roches oncology franchise Roche and Genentech sign agreement with OSI http://news2email.com/news.shtml?e13968825 HUGIN Online Phytopharm drug may help treat cancer http://news2email.com/news.shtml?e13968695 Evening Standard Cancer girl goes back to school http://news2email.com/news.shtml?e13968361 BBC Daily Cancer News - News2Email News 2 Email - http://www.news2email.com News courtesy of: ABC, APBnews, CBS, CNN, FoxNews, Moreover, USA Today. And over 2,000 other news sources. To receive this newsletter in your email inbox send a blank message to news2email-cancer-subscribeegroups Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.